GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

Innoviva INVA · USD

Health Care · US listing · 🇺🇸 United States

Compare

19.00

-0.52%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$425.1m

FY2016FY2025

Net income

$271.2m

FY2016FY2025

Free cash flow

$186.4m

FY2016FY2025

Shareholders' equity

$1.17bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$425.1m$358.7m$310.5m$331.3m$391.9m$336.8m$261.0m$261.0m$217.2m$133.6m
Research and development$30.6m$13.7m$33.9m$41.4m$576,000$1.8m$559,000—$1.4m$1.4m
Operating income$163.7m$59.6m$116.9m$216.4m$392.3m$303.2m$246.4m$238.3m$183.6m$109.0m
Net income$271.2m$23.4m$179.7m$213.9m$265.9m$224.4m$157.3m$395.1m$134.1m$59.5m
Diluted earnings per share3.180.282.113.073.251.981.393.491.130.50

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets$1.64bn$1.30bn$1.24bn$1.23bn$926.4m$999.6m$724.8m$548.2m$367.3m$379.0m
Cash and short-term investments$550.9m$412.5m$193.5m$291.0m$201.5m$246.5m$350.8m$114.9m$129.1m$150.4m
Total liabilities$462.3m$609.9m$568.6m$665.7m$400.5m$391.7m$382.7m$389.1m$610.0m$732.0m
Debt$258.1m$448.3m$446.2m$540.4m$394.7m$385.5m$377.1m$382.9m$599.4m$716.1m
Shareholders' equity$1.17bn$691.2m$675.0m$565.8m$414.7m$607.8m$313.5m$153.6m−$242.9m−$353.0m
Shares outstanding85m84m85m70m82m114m113m113m119m120m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations$196.9m$188.7m$141.1m$201.7m$363.8m$313.1m$257.5m$223.5m$141.7m$61.0m
Capital spending−$10.5m−$270,000−$411,000−$67,000−$1.3m−$13,000−$12,000−$12,000−$12,000−$278,000
Free cash flow$186.4m$188.4m$140.7m$201.7m$362.5m$313.1m$257.4m$223.5m$141.7m$60.7m
Dividends paid——−$96.3m———−$11,000−$80,000−$281,000−$960,000

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue$119.6m$98.0m$118.0m$107.8m$100.3m$88.6m$91.8m$89.5m
Operating income$50.9m$38.2m$39.0m$34.6m−$48.8m−$41.4m$43.1m$12.7m
Net income−$83.4m$186.6m$164.2m$89.9m$63.7m−$46.6m$20.3m$1.2m
Diluted earnings per share-1.142.541.931.050.75-0.550.240.01
Cash from operations$51.0m$35.0m$54.0m$49.0m$44.0m$48.0m$59.0m$48.0m
Capital spending——−$1.0m−$1.0m——−$4.0m—
Free cash flow——$53.0m$48.0m——$55.0m—
Total assets$1.70bn$1.84bn$1.64bn$1.43bn$1.33bn$1.25bn$1.30bn$1.23bn
Cash and short-term investments$579.1m$611.9m$550.9m$533.1m$497.7m$446.9m$412.5m$260.6m
Debt$259.2m$263.4m$258.1m$265.8m$449.9m$450.2m$449.9m$449.3m
Shareholders' equity$1.23bn$1.34bn$1.17bn$1.01bn$714.8m$646.9m$691.2m$668.5m

Financial ratios

Data as of 1 Nov 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Operating margin80.8%16.6%68.7%91.4%108.8%90.0%
Net margin63.8%6.5%57.9%64.6%67.8%66.6%
Return on equity23.1%3.4%26.6%37.8%64.1%36.9%
Return on assets16.6%1.8%14.5%17.4%28.7%22.4%
Free cash flow yield11.5%10.6%7.8%13.7%21.0%13.0%
Revenue growth18.5%15.5%-6.3%-15.4%16.4%29.0%
Earnings growth1059.2%-87.0%-16.0%-19.5%18.5%42.7%
Current ratio14.64x2.35x9.03x3.29x54.02x55.98x
Debt to equity0.22x0.65x0.66x1.13x0.95x0.68x
Equity ratio71.7%53.1%54.3%45.9%44.8%60.8%
Interest coverage20.57x2.68x11.13x19.17x22.35x16.54x
R&D as a share of sales7.2%3.8%10.9%12.5%0.1%0.5%
Buybacks as a share of market value-1.3%0.9%-22.0%14.8%28.0%-0.1%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue8.7%4.8%22.9%
Operating income-8.9%-11.6%17.9%
Net income8.2%3.9%—

Average margins

Over each period

1 year3 years5 years10 years
Operating margin28.5%39.0%58.1%66.9%
Net margin37.6%48.3%54.7%61.9%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings6.362.57.64.35.36.310.25.012.621.6
Price to sales4.04.14.42.83.64.26.27.67.89.6

Market value over time

30 Nov 2016 to 30 Oct 2026, in USD

$1.26bn$1.56bn

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return12%12%25%-27%45%-16%-12%15%29%5%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 8 Sept 2015.

FY2015FY2014
Paid in the year0.750.50

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.